Edward Ludwig - CVS Health Independent Director
| CVS Stock | EUR 63.56 1.80 2.75% |
Director
Mr. Edward J. Ludwig is Independent Director of the Company. He is the lead director of Aetnas board of directors and was a director at Aetna since 2003. He is the former Chairman of the board of directors of Becton, Dickinson and Company, having served in this position from February 2002 through June 2012. He also served as Chief Executive Officer of BD from January 2000 to September 2011, President of BD from May 1999 to December 2008, and Chief Financial Officer of BD from January 1995 to May 1999. Mr. Ludwig joined BD as a Senior Financial Analyst in 1979. Prior to joining BD, Mr. Ludwig was a senior auditor with Coopers and Lybrand where he earned his CPA, and served as a financial and strategic analyst at Kidde, Inc. Mr. Ludwig also served as Director of Xylem, Inc. from 2011 to 2017, and Chairman of Advanced Medical Technology Association, or AdvaMed, from 2006 to 2008. He serves as the lead independent director on the board of directors of Boston Scientific Corporation and as a director of POCARED Diagnostics Ltd. . since 2018.
| Age | 66 |
| Tenure | 6 years |
| Phone | 401-765-1500 |
| Web | https://www.cvshealth.com |
CVS Health Management Efficiency
The company has return on total asset (ROA) of 0.0418 % which means that it generated a profit of $0.0418 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0568 %, meaning that it generated $0.0568 on every $100 dollars invested by stockholders. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Margareta Nordenvall | Medicover AB | 62 | |
| Lisbet Naero | Molina Healthcare | 54 | |
| Paul Mulligan | Molina Healthcare | 48 | |
| Cecilie Fredriksen | Molina Healthcare | 34 | |
| Arno Bohn | Medicover AB | 69 | |
| Kristine Wedler | Molina Healthcare | 39 | |
| Liselotte Bergmark | Medicover AB | 57 | |
| Stein Mathiesen | Molina Healthcare | 43 | |
| Sonali Chandmal | Medicover AB | 49 | |
| Michael Flemming | Medicover AB | 61 | |
| Oyvind Oaland | Molina Healthcare | 47 | |
| Unni Svaeren | Molina Healthcare | 46 | |
| Paula Treutiger | Medicover AB | 51 | |
| Kristine Gramstad | Molina Healthcare | 36 | |
| Birgitte Vartdal | Molina Healthcare | 40 | |
| Anne Riise | Molina Healthcare | 46 | |
| Kristian Melhuus | Molina Healthcare | 36 | |
| Peder Jochnick | Medicover AB | 45 | |
| JeanPierre Bienfait | Molina Healthcare | 54 | |
| Helene Bergquist | Molina Healthcare | 57 | |
| Yngve Magnussen | Molina Healthcare | 45 | |
Management Performance
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 |
CVS Health Corp Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Ludwig, Independent Director | ||
| J Joyner, Executive Vice President | ||
| David Dorman, Independent Chairman of the Board | ||
| Shawn Guertin, Ex CFO | ||
| Richard Bracken, Independent Director | ||
| Mary Schapiro, Independent Director | ||
| Richard Swift, Independent Director | ||
| Fernando Aguirre, Independent Director | ||
| Norman Greve, Chief Officer | ||
| Laurie Havanec, Ex Officer | ||
| NancyAnn DeParle, Independent Director | ||
| Tilak Mandadi, Digital Data | ||
| David Brown, Independent Director | ||
| JeanPierre Millon, Independent Director | ||
| Mark Bertolini, Independent Director | ||
| Alecia DeCoudreaux, Independent Director | ||
| William Weldon, Independent Director | ||
| Kevin Hourican, President of CVS Pharmacy | ||
| Larry McGrath, Sr Relations | ||
| Stephen Gold, Senior Vice President CIO | ||
| Troyen Brennan, Executive Vice President Chief Medical Officer | ||
| Lisa Bisaccia, Chief Human Resource Officer, Senior Vice President | ||
| David Denton, CFO, Executive Vice President | ||
| Karen Lynch, CEO Pres | ||
| Helena Foulkes, Executive Vice President and Presidentident of CVS/pharmacy | ||
| Thomas Moriarty, Executive Vice President General Counsel | ||
| Tony White, Independent Director | ||
| Anne Finucane, Independent Director | ||
| Derica Rice, President - CVS Caremark | ||
| James Clark, Senior Vice President Chief Accounting Officer, Controller | ||
| Per Lofberg, Executive Vice President | ||
| Eva Boratto, Senior Vice President Chief Accounting Officer, Controller | ||
| David Joyner, Executive Vice President | ||
| David Falkowski, Ex Officer | ||
| Jonathan Roberts, Executive Vice President; President of CVS Caremark Pharmacy Services | ||
| Larry Merlo, President CEO, Director | ||
| Alan MD, Ex Services | ||
| Roger Farah, Independent Director | ||
| Andrew Sussman, Senior Vice President Associate Chief Medical Officer | ||
| Robert Kraft, Executive Vice President |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 173.98 B | |||
| Shares Outstanding | 1.28 B | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 82.27 % | |||
| Price To Earning | 14.93 X | |||
| Price To Book | 1.85 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CVS Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CVS Health's short interest history, or implied volatility extrapolated from CVS Health options trading.
Pair Trading with CVS Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.Moving together with CVS Stock
| 0.61 | QEN | Centene Corp Earnings Call This Week | PairCorr |
| 0.73 | MHG | Molina Healthcare Earnings Call Tomorrow | PairCorr |
Moving against CVS Stock
| 0.6 | GSR | Gossan Resources | PairCorr |
| 0.55 | HEG | Barsele Minerals Corp | PairCorr |
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for CVS Stock analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |